Response to “Evaluating Adverse Events in Databases”
Main Authors: | Fabrizio Calapai, Carmen Mannucci, Luigi Cardia, Mariaconcetta Currò, Gioacchino Calapai, Emanuela Esposito, Ilaria Ammendolia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Pharmacology Research & Perspectives |
Online Access: | https://doi.org/10.1002/prp2.1127 |
Similar Items
-
Adverse Reactions to Evolocumab: Analysis of Real-World Data from EudraVigilance
by: Fabrizio Calapai, et al.
Published: (2024-03-01) -
Suspected oncologic adverse reactions associated with interleukin‐23 inhibitors in EudraVigilance: Comparative study and gender distribution
by: Fabrizio Calapai, et al.
Published: (2023-10-01) -
Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database
by: Fabrizio Calapai, et al.
Published: (2023-07-01) -
Pharmacovigilance on cannabidiol as an antiepileptic agent
by: Ilaria Ammendolia, et al.
Published: (2023-02-01) -
Effects of Cannabidiol on Locomotor Activity
by: Fabrizio Calapai, et al.
Published: (2022-04-01)